» Articles » PMID: 34379316

Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective

Overview
Journal Pulm Ther
Publisher Springer
Date 2021 Aug 11
PMID 34379316
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Impressive advances in inhalation therapy for patients with asthma and chronic obstructive pulmonary disease (COPD) have occurred in recent years. However, important gaps in care remain, particularly relating to poor adherence to inhaled therapies. Digital inhaler health platforms which incorporate digital inhalers to monitor time and date of dosing are an effective disease and medication management tool, promoting collaborative care between clinicians and patients, and providing more in-depth understanding of actual inhaler use. With advances in technology, nearly all inhalers can be digitalized with add-on or embedded sensors to record and transmit data quantitating inhaler actuations, and some have additional capabilities to evaluate inhaler technique. In addition to providing an objective and readily available measure of adherence, they allow patients to interact with the device directly or through their self-management smartphone application such as via alerts and recording of health status. Clinicians can access these data remotely and during patient encounters, to better inform them about disease status and medication adherence and inhaler technique. The ability for remote patient monitoring is accelerating interest in and the use of these devices in clinical practice and research settings. More than 20 clinical studies of digital inhalers in asthma or COPD collectively show improvement in medication adherence, exacerbation risk, and patient outcomes with digital inhalers. These studies support previous findings about patient inhaler use and behaviors, but with greater granularity, and reveal some new findings about patient medication-taking behaviors. Digital devices that record inspiratory flows with inhaler use can guide proper inhaler technique and may prove to be a clinically useful lung function measure. Adoption of digital inhalers into practice is still early, and additional research is needed to determine patient and clinician acceptability, the appropriate place of these devices in the therapeutic regimen, and their cost effectiveness. Video: Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective (MP4 74535 kb).

Citing Articles

Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects.

Dallal Bashi Y, Mairs R, Murtadha R, Kett V Pharmaceutics. 2025; 17(1).

PMID: 39861758 PMC: 11768398. DOI: 10.3390/pharmaceutics17010111.


A Review of Sensor-Based Interventions for Supporting Patient Adherence to Inhalation Therapy.

Ma J, Sun X, Liu B Patient Prefer Adherence. 2024; 18:2397-2413.

PMID: 39650574 PMC: 11624667. DOI: 10.2147/PPA.S485553.


Asthma management in the digital age.

Bocian I, Chin A, Rodriguez A, Collins W, Sindher S, Chinthrajah R Front Allergy. 2024; 5:1451768.

PMID: 39291253 PMC: 11405314. DOI: 10.3389/falgy.2024.1451768.


Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler.

Levy M, Kocks J, Bosnic-Anticevich S, Safioti G, Reich M, DePietro M NPJ Prim Care Respir Med. 2024; 34(1):23.

PMID: 39164292 PMC: 11336086. DOI: 10.1038/s41533-024-00382-x.


The application of nanoparticles as advanced drug delivery systems in Attenuating COPD.

Jessamine V, Mehndiratta S, De Rubis G, Paudel K, Shetty S, Suares D Heliyon. 2024; 10(3):e25393.

PMID: 38356590 PMC: 10864912. DOI: 10.1016/j.heliyon.2024.e25393.


References
1.
Garantziotis S, Schwartz D . Ecogenomics of respiratory diseases of public health significance. Annu Rev Public Health. 2010; 31:37-51 1 p following 51. PMC: 3402173. DOI: 10.1146/annurev.publhealth.012809.103633. View

2.
Dima A, Hernandez G, Cunillera O, Ferrer M, de Bruin M . Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J. 2014; 45(4):994-1018. DOI: 10.1183/09031936.00172114. View

3.
Williams L, Peterson E, Wells K, Ahmedani B, Kumar R, Burchard E . Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011; 128(6):1185-1191.e2. PMC: 3229671. DOI: 10.1016/j.jaci.2011.09.011. View

4.
Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B . Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000; 343(5):332-6. DOI: 10.1056/NEJM200008033430504. View

5.
Williams L, Pladevall M, Xi H, Peterson E, Joseph C, Lafata J . Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004; 114(6):1288-93. DOI: 10.1016/j.jaci.2004.09.028. View